Healthcare China Growth Stage
Shanghai, CN · 2 known investors
Spectrumedics develops the Sonico-CX intravascular lithotripsy (shockwave) system for treating calcified coronary artery disease, delivering 360° circumferential shockwave pulses through a low-profile catheter. The medical device company serves interventional cardiologists and has received regulatory approval to market its product.
HardwareHealthtechMedical Devices
Investors · 2
.jpeg){kind=logo}
In the news
Frequently asked questions
- What does Healthcare China Growth Stage do?
- Spectrumedics develops the Sonico-CX intravascular lithotripsy (shockwave) system for treating calcified coronary artery disease, delivering 360° circumferential shockwave pulses through a low-profile catheter. The medical device company serves interventional cardiologists and has received regulatory approval to market its product.
- Who are Healthcare China Growth Stage's investors?
- Healthcare China Growth Stage's investors include B Capital Group, B4 Capital.
- Where is Healthcare China Growth Stage headquartered?
- Healthcare China Growth Stage is headquartered in Shanghai, CN.